The FDA has ordered a warning label be put on the diabetes drugs
Avandia and Actos due to evidence from studies that the
medications may increase the risk of heart attack or death from
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.